Skip to content
The Policy VaultThe Policy Vault

Mirvaso (brimonidine gel) — United Healthcare

rosacea

Initial criteria

  • Diagnosis of rosacea

Reauthorization criteria

  • Documentation of positive clinical response to therapy

Approval duration

12 months